Inventor · disambiguated record
Paolo La Colla
Also filed as: LA COLLA PAOLO
5 granted patents·6 pending applications·39 citations·filing 1999–2020
77Inventor score
Files withIDENIX PHARMACEUTICALS LLC6GOSSELIN GILLES1IDENIX CAYMAN LTD1IDENIX PHARMACEUTICALS INC1LA COLLA PAOLO1
Top patents by PatentIndex Score
11 records- 0188US6545007B2Methods for inhibiting the transmission of HIV using topically applied substituted 6-benzyl-4-oxopyrimidinesIDENIX CAYMAN LTD·Filed 2001·Granted Apr 8, 2003·24 cites·43 claims
- 0276US2021024565A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS LLC·Filed 2020·Application pending·0 cites
- 0373US10758557B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS LLC·Filed 2019·Granted Sep 1, 2020·0 cites·19 claims
- 0473US10363265B2Methods and compositions for treating hepatitis C virusIDENIX PHARMACEUTICALS LLC·Filed 2012·Granted Jul 30, 2019·1 cites·33 claims
- 0573US2018237467A1Modified 2' and 3'-nucleoside prodrugs for treating flaviviridae infectionsIDENIX PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 0670US6635636B1Substituted 6-benzyl-4-oxopyrimidines, process for their preparation and pharmaceutical compositions containing themIDENIX PHARMACEUTICALS INC·Filed 1999·Granted Oct 21, 2003·14 cites·49 claims
- 0765US2018235993A1Methods and compositions for treating flaviviruses and pestivirusesIDENIX PHARMACEUTICALS LLC·Filed 2018·Application pending·0 cites
- 0854US10525072B22′-branched nucleosides and flaviviridae mutationIDENIX PHARMACEUTICALS LLC·Filed 2015·Granted Jan 7, 2020·0 cites·12 claims
- 0942US2005014774A1Oxo-pyrimidine compoundsFiled 2004·Application pending·0 cites
- 1041US2006040944A15-Aza-7-deazapurine derivatives for treating FlaviviridaeGOSSELIN GILLES·Filed 2005·Application pending·0 cites
- 1140US2009305258A1Methods for the diagnosis of proliferative and/or conformational diseasesLA COLLA PAOLO·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →